Expert opinion on expanding anti-HBV treatment for chronic hepatitis B / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 131-136, 2022.
Artigo
em Chinês
| WPRIM
| ID: wpr-928459
ABSTRACT
To meet the unmet medical needs and better reflect the new clinical evidence of chronic hepatitis B management, Chinese Society of Hepatology developed expert consensus on expanding diagnosis and treatment in China. The recommendations include to expand HBsAg screening in the population and HBV DNA detection by sensitive quantitative real-time PCR (qPCR), decrease the alanine aminotransferase (ALT) threshold for treatment of chronic hepatitis B, and promptly start antiviral therapy in the patients who are at risk of disease progression, and appropriately manage the patients with low level viremia.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
DNA Viral
/
Hepatite B Crônica
/
Alanina Transaminase
/
Prova Pericial
/
Antígenos de Superfície da Hepatite B
Tipo de estudo:
Guia de Prática Clínica
Limite:
Humanos
Idioma:
Chinês
Revista:
Chinese Journal of Hepatology
Ano de publicação:
2022
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS